Alerts
Other content recommended for you
- Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation
- Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period
- Gender-specific differences in clinical outcome of primary prevention implantable cardioverter defibrillator recipients
- Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score
- Myocardial scar burden predicts survival benefit with implantable cardioverter defibrillator implantation in patients with severe ischaemic cardiomyopathy: influence of gender
- Incidence of left ventricular function improvement after primary prevention ICD implantation for non-ischaemic dilated cardiomyopathy: a multicentre experience
- Republished: How to reduce sudden cardiac death in patients with renal failure
- How to reduce sudden cardiac death in patients with renal failure
- The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy
- Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis